Dr. Imogen Coe
Dr. Imogen R. Coe was the founding dean of the Faculty of Science from 2012 to 2018 and is a professor of Chemistry and Biology at Ryerson University in Toronto. She is also an affiliate scientist at St. Michael’s Hospital, Toronto, where her research group studies the cell biology of proteins responsible for the uptake of anti-cancer drugs. She is the incoming President of the Canadian Molecular Biosciences Society and sits on various boards, including the Michael Garron Hospital and Science Rendezvous.
In addition to her work as a research scientist, Dr. Coe is internationally recognized as a leading voice in Canada on how to integrate principles of inclusion, diversity equity, and accessibility (IDEA) into science, technology, engineering, math and medicine (STEMM). She has advised academia, government and industry on best practices and approaches to improve IDEA and has contributed to national dialogue about these issues through various platforms. She is much in demand as a speaker and panelist and has received numerous awards for her advocacy work.